术前血液中性粒细胞淋巴细胞比值和球蛋白与上尿路尿路上皮癌预后相关性研究进展
Research Progress in the Correlation between Preoperative Neutrophil Lymphocyte Ratio and Globulin in Blood and Prognosis of Upper Urinary Tract Epithelial Carcinoma
摘要: 上尿路尿路上皮癌(upper tract urothelial carcinoma, UTUC)是比较罕见但恶性程度较高的，起源于上尿路尿路上皮的恶性肿瘤，其发病率约占尿路上皮癌的5%~10%。近年来UTUC发病率呈上升趋势，由于其术后复发转移风险较高，接受外科手术治疗后的患者预后仍然不是很理想。相比于传统的预后预测模型，能够捕捉肿瘤行为和反映侵袭性的血液生物标志物可以术前获取，创伤性小，能够为UTUC患者术前干预、术后治疗及随访提供依据。本综述概述了血液中性粒细胞淋巴细胞比值和球蛋白与UTUC患者预后相关研究的进展。
Abstract: Upper urinary tract epithelial carcinoma (UTUC) is a relatively rare but highly malignant tumor originating from the upper urinary tract epithelium, and its incidence rate accounts for about 5%~10% of urinary tract epithelial carcinoma. In recent years, the incidence rate of UTUC is on the rise. Because of its high risk of recurrence and metastasis after surgery, the prognosis of patients receiving surgical treatment is still not ideal. Compared to traditional prognostic prediction models, blood biomarkers that can capture tumor behavior and reflect invasiveness can be obtained pre-operative with minimal trauma, providing a basis for preoperative intervention, postoperative treatment, and follow-up in patients with UTUC. This review summarizes the progress of research on the relationship between blood neutrophil lymphocyte ratio, globulin, and prognosis in patients with UTUC.
文章引用：艾克拜尔江·卡米力, 木拉提·热夏提. 术前血液中性粒细胞淋巴细胞比值和球蛋白与上尿路尿路上皮癌预后相关性研究进展[J]. 临床医学进展, 2023, 13(6): 8934-8940. https://doi.org/10.12677/ACM.2023.1361250

参考文献

[1] Nishikawa, M., Miyake, H., Kurahashi, T. and Fujisawa, M. (2018) Significance of Multiple Preoperative Laboratory Abnormalities as Prognostic Indicators in Patients with Urothelial Carcinoma of the Upper Urinary Tract Following Rad-ical Nephroureterectomy. International Journal of Clinical Oncology, 23, 151-157. [Google Scholar] [CrossRef] [PubMed]
[2] Colin, P., Koenig, P., Ouzzane, A., et al. (2009) Environmental Factors Involved in Carcinogenesis of Urothelial Cell Carcinomas of the Upper Urinary Tract. BJU International, 104, 1436-1440. [Google Scholar] [CrossRef] 
[3] 许永德, 吉正国, 胡新一, 杨培谦. 上尿路尿路上皮癌: 应重视的恶性肿瘤[J]. 中国医刊, 2021, 56(6): 581-584+ 576.
[4] 方冬, 李学松. 《上尿路尿路上皮癌诊断与治疗中国专家共识》解读[J]. 西部医学, 2019, 31(7): 990-993.
[5] Cosentino, M., Palou, J., Gaya, J.M., et al. (2013) Upper Urinary Tract Urothelial Cell Carcinoma: Location as a Predictive Factor for Concomitant Bladder Carcinoma. World Journal of Urology, 31, 141-145. [Google Scholar] [CrossRef] [PubMed]
[6] Xiong, G., et al. (2014) Prevalence and Factors Associated with Baseline Chronic Kidney Disease in China: A 10-Year Study of 785 Upper Urinary Tract Urothelial Carcinoma Patients. Journal of the Formosan Medical Association, 113, 521-526. [Google Scholar] [CrossRef] [PubMed]
[7] Jung, H., Giusti, G., Fajkovic, H., et al. (2019) Consultation on UTUC, Stockholm 2018: Aspects of Treatment. World Journal of Urology, 37, 2279-2287. [Google Scholar] [CrossRef] [PubMed]
[8] Shvero, A. and Hubosky, S.G. (2022) Management of Upper Tract Urothelial Carcinoma. Current Oncology Reports, 24, 611-619. [Google Scholar] [CrossRef] [PubMed]
[9] Aurélie, M., Morgan, R., Ashish, M.K., et al. (2017) Prognostic Factors and Predictive Tools for Upper Tract Urothelial Carcinoma: A Systematic Review. World Journal of Urology, 35, 337-353. [Google Scholar] [CrossRef] [PubMed]
[10] Mori, K., Janisch, F., Mostafaei, H., et al. (2020) Prognostic Val-ue of Preoperative Blood-Based Biomarkers in Upper Tract Urothelial Carcinoma Treated with Nephroureterectomy: A Systematic Review and Meta-Analysis. Urologic Oncology: Seminars and Original Investigations, 38, 315-333. [Google Scholar] [CrossRef] [PubMed]
[11] Xia, C.F., Dong, X., Li, H., et al. (2022) Cancer Statistics in China and United States, 2022: Profiles, Trends and Determinants. Chinese Medical Journal, 135, 584-590. [Google Scholar] [CrossRef] 
[12] 林家俞, 秦洁洁, 蒋玲曦. 肿瘤微环境中免疫细胞的代谢研究进展[J]. 上海交通大学学报(医学版), 2022, 42(8): 1122-1130.
[13] Gonda, T.A., Tu, S., Wang, T.C., 丁燕, 南娟. 慢性炎症、肿瘤微环境与癌变[J]. 中国肺癌杂志, 2009, 12(9): 1022-1031.
[14] Wen, Y., Zhu, Y., Zhang, C., Yang, X., Gao, Y., Li, M., Yang, H., Liu, T. and Tang, H. (2022) Chronic Inflammation, Cancer Development and Im-munotherapy. Frontiers in Pharmacology, 13, Article 1040163. [Google Scholar] [CrossRef] [PubMed]
[15] Vu, T. and Datta, P.K. (2017) Regulation of EMT in Colorectal Cancer: A Culprit in Metastasis. Cancers, 9, Article 171. [Google Scholar] [CrossRef] [PubMed]
[16] Faustino, M. (2019) Neutrophil Degranulation, Plasticity and Cancer Metastasis. Trends in Immunology, 40, 228-242. [Google Scholar] [CrossRef] [PubMed]
[17] Fridlender, Z.G., Sun, J., Samuel, K., Kapoor, V., Cheng, G., Ling L., Worthen, G.S. and Albelda, S.M. (2009) Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” ver-sus “N2” TAN. Cancer Cell, 16, 183-194. [Google Scholar] [CrossRef] [PubMed]
[18] Antonio, N., Bønnelykke-Behrndtz, M.L., Ward, L.C., et al. (2015) The Wound Inflammatory Response Exacerbates Growth of Pre-Neoplastic Cells and Progression to Cancer. EMBO Journal, 34, 2219-2236. [Google Scholar] [CrossRef] [PubMed]
[19] 李艳双, 杨丽娟. 肿瘤微环境中淋巴细胞的种类与功能研究进展[J]. 河北联合大学学报(医学版), 2016, 18(3): 245-249. [Google Scholar] [CrossRef] 
[20] Ignacio, M., Berman, D.M., Aznar, M.A., Korman, A.J., Gracia, J.L.P. and Haanen, J. (2015) Evolving Synergistic Combinations of Targeted Immunotherapies to Combat Cancer. Nature Reviews Cancer, 15, 457-472. [Google Scholar] [CrossRef] [PubMed]
[21] Whiteside, T.L. (2008) The Tumor Microenvironment and Its Role in Pro-moting Tumor Growth. Oncogene, 27, 5904- 5912. [Google Scholar] [CrossRef] [PubMed]
[22] Giuseppe, B., Dan-iele, F., Lorena, I., et al. (2019) Role of Tumor-Infiltrating Lymphocytes in Patients with Solid Tumors: Can a Drop Dig a Stone? Cellular Immunology, 343, Article ID: 103753. [Google Scholar] [CrossRef] [PubMed]
[23] Mohamad, M., Shravani, R., Miranda, G., Boardman, L. and Rubio, M. (2021) Usefulness of Neutrophil-to-Lymphocyte Ratio (NLR) as a Prognostic Predictor after Treatment of Hepatocellular Carcinoma. Review article. Annals of Hepatology, 22, Article ID: 100249. [Google Scholar] [CrossRef] [PubMed]
[24] Vartolomei, M.D., Mathieu, R., Margulis, V., et al. (2017) Promising Role of Preoperative Neutrophil-to-Lymphocyte Ratio in Patients Treated with Radical Nephroureterectomy. World Journal of Urology, 35, 121-130. [Google Scholar] [CrossRef] [PubMed]
[25] Cheng, T., Hu, C., Wu, K., et al. (2022) Pre-Existing Renal Insuf-ficiency Synchronous with High Preoperative Neutrophil-to-Lymphocyte Ratio as a Risk Factor of Intravesical Recur-rence in Patients with Pure Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy. Experimental and Therapeutic Medicine, 24, Article No. 671. [Google Scholar] [CrossRef] [PubMed]
[26] Yuan, S., Li, W., Wang, D. and Wu, B. (2020) Prognostic Value of Preoperative Lymphocyte-Related Systemic Inflammatory Biomarkers in Upper Tract Urothelial Carcinoma Patients Treated with Radical Nephroureterectomy: A Systematic Review and Meta-Analysis. World Journal of Surgical Oncolo-gy, 18, Article No. 273. [Google Scholar] [CrossRef] [PubMed]
[27] Alessandro, U., Rodolfo, H., Roberto, C., et al. (2022) Combi-nation of AST to ALT and Neutrophils to Lymphocytes ratios as Predictors of Locally Advanced Disease in Patients with Bladder Cancer Subjected to Radical Cystectomy: Results from a Single-Institutional Series. Urologia Journal, 89, 363-370. [Google Scholar] [CrossRef] [PubMed]
[28] Cieszymierz, G., Wojciech, M., Andrzej, M. and Lucjan, W. (2022) Correlation between Lymphocyte-to-Monocyte Ratio (LMR), Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Tumor-Infiltrating Lymphocytes (TILs) in Left-Sided Colorectal Cancer Patients. Biology, 11, Article 385. [Google Scholar] [CrossRef] [PubMed]
[29] Teerapat, M., Karicha, M., Yenrudee, P., et al. (2022) Study on Preoperative Neutrophil/Lymphocyte (NLR) and Platelet/Lymphocyte Ratio (PLR) as a Predictive Factor in Endometrial Cancer. The Asian Pacific Journal of Cancer Prevention, 23, 3317-3322. [Google Scholar] [CrossRef] 
[30] Li, Q., Meng, X.K., Liang, L., et al. (2015) High Preopera-tive Serum Globulin in Rectal Cancer Treated with Neoadjunctive Chemoradiation Therapy Is a Risk Factor for Poor Outcome. The American Journal of Cancer Research, 5, 2856-2864.
[31] Omura, S., Taguchi, S., Miyagawa, S., et al. (2020) Prognostic Significance of the Albumin-to-Globulin Ratio for Upper Tract Urothelial Carcinoma. BMC Urology, 20, Article No. 133. [Google Scholar] [CrossRef] [PubMed]
[32] Zhong, L., Wang, H., Liang, H., et al. (2016) [An Elevated Pretreatment Serum Globulin Level Predicts a Poor Prognosis of Nasopharyngeal Carcinoma]. Journal of Southern Medical University, 36, 151-156. (In Chinese)
[33] Zhang, W., Zhangyuan, G., Wang, F., Zhang, H., Yu, D., Wang, J., Jin, K., Yu, W., Liu, Y. and Sun, B. (2019) High Preoperative Serum Globulin in Hepatocellular Carcinoma Is a Risk Factor for Poor Survival. Journal of Cancer, 10, 3494-3500. [Google Scholar] [CrossRef] [PubMed]
[34] Chen, J., Zhou, Y., Xu, Y., Zhu, H. and Shi, Y. (2016) Low Pretreatment Serum Globulin May Predict Favorable Prognosis for Gastric Cancer Patients. Tumor Biology, 37, 3905-3911. [Google Scholar] [CrossRef] [PubMed]
[35] Liu, J., Dai, Y.B., Zhou, F.J., et al. (2016) The Prognostic Role of Preoperative Serum Albumin/Globulin Ratio in Patients with Bladder Urothelial Carcinoma Undergoing Radical Cystectomy. Urologic Oncology: Seminars and Original Investiga-tions, 34, e1-484. [Google Scholar] [CrossRef] [PubMed]
[36] Oh, J.S., Park, D.J., Byeon, K.-H., et al. (2021) Decrease of Preoperative Serum Albumin-to-Globulin Ratio as a Prognostic Indicator after Radical Cystectomy in Patients with Urothelial Bladder Cancer. Urology Journal, 18, 66-73.
[37] Chung, J.-W., Ha, Y.-S., Won, K.S., et al. (2021) The Prognostic Value of the Pretreatment Serum Albumin to Globulin Ratio for Predicting Adverse Pathology in Patients Undergoing Radical Prostatectomy for Prostate Cancer. Investigative and Clinical Urology, 62, 545-552. [Google Scholar] [CrossRef] [PubMed]
[38] Xu, H., Tan, P., Ai, J., et al. (2018) Prognostic Impact of Preoperative Albumin-Globulin Ratio on Oncologic Outcomes in Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy. Clinical Genitourinary Cancer, 16, e1059-e1068. [Google Scholar] [CrossRef] [PubMed]
[39] Lv, G.-Y., An, L., Sun, X.-D., Hu, Y. and Sun, D. (2018) Pre-treatment Albumin to Globulin Ratio Can Serve as a Prognostic Marker in Human Cancers: A Meta-Analysis. Clinica Chimica Acta, 476, 81-91.

为你推荐